Latest Biotechnology News

Carson City, Nevada--(Newsfile Corp. - June 28, 2019) - Cell MedX Corp. (OTCQB: CMXC), ("Cell MedX" or the "Company"), a bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that on June 24, 2019, the Company closed ...
Biotechnology, Pharmaceuticals, Health
2019-06-28 10:12 AM ET | Cell MedX Corp

Sacramento California--(Newsfile Corp. - June 28, 2019) - Conception, a leading cannabis micropropagation company, is pleased to announce the hire of strong industry leader Tad Henderson as Chief Operating Officer (COO). Henderson brings to the Conception team 20-plus years of leadership and operational excellence in highly-regulated environments. As COO, ...
Biotechnology, Cannabis
2019-06-28 9:05 AM ET | Conception

Currently no effective treatment exists for the 20,000 children in the U.S. and 250,000 born worldwide each year with pediatric minimally verbal autism (PMVA)New York, New York--(Newsfile Corp. - June 28, 2019) - Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today it has filed an application ...
Biotechnology, Health
2019-06-28 7:30 AM ET | Q BioMed Inc.

New York, New York--(Newsfile Corp. - June 24, 2019) - Q BioMed Inc. (OTCQB: QBIO), is providing this response at the request of the OTC markets inquiry into recent expanded investor awareness activities undertaken by the Company. As part of the company's effort to bring awareness to our development of ...
Biotechnology, Health
2019-06-24 4:00 PM ET | Q BioMed Inc.

Carson City, Nevada--(Newsfile Corp. - June 21, 2019) - Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announced today that it has retained Think Ink Marketing ...
Biotechnology, Pharmaceuticals, Health
2019-06-21 7:55 PM ET | Cell MedX Corp

Vancouver, British Columbia--(Newsfile Corp. - June 21, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce the appointments of Keith Anderson and Mark Lotz to the board of directors of the Company (the "Board"), effective immediately.Stephen Van Deventer, PreveCeutical's ...
Biotechnology, Pharmaceuticals, Health
2019-06-21 10:08 AM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide positive results from research conducted for its dual gene therapy research program (the "Program").PreveCeutical previousl
Biotechnology, Pharmaceuticals, Health
2019-06-17 7:00 AM ET | PreveCeutical Medical Inc.

No effective treatment exists for the estimated 250,000 children born worldwide each year with pediatric minimally verbal autism (PMVA), of those approximately 20,000 are born in the U.S.Orphan Drug designation application to be filed in June 2019 based on Q BioMed's recent breakthrough discovery of disease biomarkersShort 12 month pivotal ...
Biotechnology, Health
2019-06-04 7:30 AM ET | Q BioMed Inc.

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that it has received a loan in the aggregate amount of $300,000 (the "Loan") pursuant to a loan agreement with the Company's Chairman and Chief Executive Officer, ...
Biotechnology, Pharmaceuticals, Health
2019-06-03 7:00 AM ET | PreveCeutical Medical Inc.

Carson City, Nevada--(Newsfile Corp. - May 30, 2019) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, has arranged a non-brokered private placement offering (the "Offering") set at a ...
Biotechnology, Pharmaceuticals, Health
2019-05-30 1:22 PM ET | Cell MedX Corp

Vancouver, British Columbia--(Newsfile Corp. - May 21, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that the Company's research team at the University of Queensland has been granted the necessary approvals from a local hospital's Human Ethics Committee to acquire and use ...
Biotechnology, Pharmaceuticals, Health
2019-05-21 7:00 AM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - May 16, 2019) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (formerly Gravis Energy Corp.) (the "Company" or "Biocure") is pleased to announce that Biocure Pharm Corp.("BPK"), a subsidiary of the Company has entered into an agreement with Pharos Vaccine Inc. for the development of ...
Biotechnology, Pharmaceuticals, Health
2019-05-16 7:40 AM ET | Biocure Technology Inc.

New York, New York--(Newsfile Corp. - April 24, 2019) - Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, announced today its technology partner Mannin Research will be attending ARVO 2019 the Annual Meeting of the Association for Research in Vision and Ophthalmology from April 28 to May 2, ...
Biotechnology, Health
2019-04-24 7:00 AM ET | Q BioMed Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 17, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company's research collaboration with UniQuest and The University of Queensland ("UQ") has led to the filing of two new patent applications for cyclic peptides ...
Biotechnology, Pharmaceuticals, Health
2019-04-17 9:35 AM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the Company's research team at the University of Queensland has filed an application to a local hospital's Human Ethics Committee (the "Human Ethics Committee") to acquire ...
Biotechnology, Pharmaceuticals, Health
2019-04-15 7:30 AM ET | PreveCeutical Medical Inc.

New York, New York--(Newsfile Corp. - April 12, 2019) - Genprex Inc. (NASDAQ: GNPX) announces the availability of a NetworkNewsAudio broadcast titled, "Potential Blockbuster Gene Therapy Programs to Watch in 2019."To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/j1WMsTo read the full editorial, visit:
Biotechnology, Health
2019-04-12 8:00 AM ET | Genprex, Inc.

New York, New York--(Newsfile Corp. - April 11, 2019) - Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.To view the full publication, titled "Potential Blockbuster Gene Therapy Programs to Watch in ...
Biotechnology, Health
2019-04-11 7:30 AM ET | Genprex, Inc.

Marks the first time a company has identified biomarkers that hold the potential to stratify this subset of patientsStudy examined 1,953 significant autistic biomarkers, resulting in 2 significant markers tied to expressed genes and pathways responsible for speech developmentBiomarkers in the nonverbal subset were distinct from children with typical speech ...
Biotechnology, Health
2019-04-10 7:30 AM ET | Q BioMed Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 10, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce further positive results from the preliminary screening of key peptides from its scorpion venom-derived peptide research and development program (the "Peptide Program"), that is ...
Biotechnology, Pharmaceuticals, Health
2019-04-10 7:30 AM ET | PreveCeutical Medical Inc.

Baltimore, Maryland--(Newsfile Corp. - April 9, 2019) - Dr. Henry Lowe, the executive Chairman of Flavocure Biotech Inc, today announced that Denning Growth Fund ("DGF") has invested $1.5 million USD in Flavocure Biotech, Inc. a disruptive innovator in oncological drug discovery. DGF, which is controlled by one of Asia's ...
Biotechnology, Pharmaceuticals, Cannabis, Health
2019-04-09 11:19 AM ET | Flavocure Biotech Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 8, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has obtained a default judgement against JCN Capital Corp. ("JCN") in connection with a Supreme Court of British Columbia action (the "Action"). The Action ...
Biotechnology, Pharmaceuticals, Health
2019-04-08 8:35 AM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that, at the request of the Investment Industry Regulatory Organization of Canada, it hereby retracts certain statements regarding estimated annual production, valuation and harvest quantities from the ...
Biotechnology, Pharmaceuticals, Health
2019-04-04 4:09 PM ET | PreveCeutical Medical Inc.

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2019) - Asterion Cannabis Inc. (P.ASTR) ("Asterion") and PreveCeutical Medical Inc. ("PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announce today that Asterion's wholly-owned Australian subsidiary, Asterion Australia Pty Ltd, has been awarded Major Project Status for Asterion's Toowoomba Medicinal Cannabis Project (the "Toowoomba ...
Biotechnology, Pharmaceuticals, Health
2019-04-04 1:40 PM ET | PreveCeutical Medical Inc.

New York, New York--(Newsfile Corp. - March 29, 2019) - Genprex Inc. (NASDAQ: GNPX) announces the availability of a NetworkNewsAudio publication titled, "Advanced Medical Technologies Provides Unprecedented Targeting in Cancer Therapy."To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/XRt4dTo read the full editorial, visit:
Biotechnology, Health
2019-03-29 8:00 AM ET | Genprex, Inc.

New York, New York--(Newsfile Corp. - March 28, 2019) - Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities.To view the full publication, titled "Advanced Medical Technologies Provides Unprecedented Targeting in ...
Biotechnology, Health
2019-03-28 7:30 AM ET | Genprex, Inc.